| 1 |
The repertoire of mutational signatures in human cancer
Ludmil B. Alexandrov et al. · Nature
Open access1,384 authors |
5 Feb 2020 |
3,854 |
| 2 |
Pan-cancer analysis of whole genomes
Lauri A. Aaltonen et al. · Nature
Open access1,324 authors |
5 Feb 2020 |
3,360 |
| 3 |
International network of cancer genome projects
Jennifer L. Jennings et al. · Nature
Open access256 authors |
13 Apr 2010 |
2,439 |
| 4 |
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
Serena Nik‐Zainal et al. · Nature
Open access |
29 Apr 2016 |
2,395 |
| 5 |
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
Cécile Guichard, Giuliana Amaddeo, Sandrine Imbeaud et al. · Nature Genetics
Open access |
6 May 2012 |
1,489 |
| 6 |
The evolutionary history of 2,658 cancers
Moritz Gerstung et al. · Nature
Open access1,441 authors |
5 Feb 2020 |
1,149 |
| 7 |
Patterns of somatic structural variation in human cancer genomes
Yilong Li et al. · Nature
Open access1,411 authors |
5 Feb 2020 |
1,005 |
| 8 |
Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer
gastric · JAMA
|
4 May 2010 |
806 |
| 9 |
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
Isidro Cortés-Ciriano et al. · Nature Genetics
Open access1,407 authors |
5 Feb 2020 |
793 |
| 10 |
SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma
Éric Letouzé, Cosimo Martinelli, Céline Loriot et al. · Cancer Cell
Open access |
23 May 2013 |
790 |
| 11 |
Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
Esther Rheinbay et al. · Nature
Open access1,621 authors |
5 Feb 2020 |
674 |
| 12 |
SDHA is a tumor suppressor gene causing paraganglioma
Nelly Burnichon, Jean-Jacques Brière, Rossella Libé et al. · Human Molecular Genetics
Open access |
18 May 2010 |
654 |
| 13 |
The Impact of Nutrition and Environmental Epigenetics on Human Health and Disease
Céline Tiffon · International Journal of Molecular Sciences
Open access |
Nov 2018 |
504 |
| 14 |
Genomic basis for RNA alterations in cancer
PCAWG Transcriptome Core Group et al. · Nature
Open access1,461 authors |
5 Feb 2020 |
425 |
| 15 |
The landscape of viral associations in human cancers
Marc Zapatka et al. · Nature Genetics
Open access1,355 authors |
5 Feb 2020 |
412 |
| 16 |
6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial
Xavier Pivot, Gilles Romieu, Marc Debled et al. · The Lancet Oncology
|
11 Jun 2013 |
343 |
| 17 |
Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma
Nelly Burnichon, Laure Vescovo, Laurence C. Amar et al. · Human Molecular Genetics
Open access |
22 Jul 2011 |
311 |
| 18 |
Genomic Profiling of Hepatocellular Adenomas Reveals Recurrent FRK-Activating Mutations and the Mechanisms of Malignant Transformation
Camilla Pilati et al. · Cancer Cell
Open access |
Apr 2014 |
273 |
| 19 |
Mapping low intake of micronutrients across Europe
Gert Mensink, Richard A. Fletcher, Mirjana A Gurinović et al. · British Journal Of Nutrition
Open access |
14 Jan 2013 |
266 |
| 20 |
Prognostic factors in stage III–IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study
Rossella Libé et al. · Annals of Oncology
Open access |
21 Sep 2015 |
262 |
| 21 |
Alcohol and genetic polymorphisms: effect on risk of alcohol-related cancer
Nathalie Druesne‐Pecollo, B. Téhard, Yann Mallet et al. · The Lancet Oncology
|
30 Jan 2009 |
256 |
| 22 |
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns
Wei Jiao et al. · Nature Communications
Open access1,385 authors |
5 Feb 2020 |
246 |
| 23 |
Integrative pathway enrichment analysis of multivariate omics data
Marta Paczkowska et al. · Nature Communications
Open access1,460 authors |
5 Feb 2020 |
243 |
| 24 |
The Warburg Effect Is Genetically Determined in Inherited Pheochromocytomas
Judith Favier, Jean-Jacques Brière, Nelly Burnichon et al. · PLoS ONE
Open access |
18 Sep 2009 |
233 |
| 25 |
Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses
Menglin Wang et al. · Nature Biotechnology
Open access |
25 Sep 2023 |
209 |
| 26 |
SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma
Julien Hadoux, Judith Favier, Jean‐Yves Scoazec et al. · International Journal of Cancer
Open access |
19 Apr 2014 |
208 |
| 27 |
Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trial
Denis Moro‐Sibilot et al. · Annals of Oncology
Open access |
27 Sep 2019 |
199 |
| 28 |
Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis
Joana Carlevaro-Fita et al. · Communications Biology
Open access1,462 authors |
5 Feb 2020 |
195 |
| 29 |
Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations
Julien Mazières et al. · Annals of Oncology
Open access |
6 Jan 2020 |
193 |
| 30 |
Adherence to the French Programme National Nutrition Santé Guideline Score Is Associated with Better Nutrient Intake and Nutritional Status
Carla Estaquio, Emmanuelle Kesse‐Guyot, Valérie Deschamps et al. · Journal of the American Dietetic Association
|
22 May 2009 |
193 |
| 31 |
Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells
Young Seok Ju et al. · Genome Research
Open access |
11 May 2015 |
178 |
| 32 |
Underrepresentation of Elderly People in Randomised Controlled Trials. The Example of Trials of 4 Widely Prescribed Drugs
Cécile Konrat, Isabelle Boutron, Ludovic Trinquart et al. · PLoS ONE
Open access |
30 Mar 2012 |
170 |
| 33 |
A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers
Anthony Ferrari et al. · Nature Communications
Open access |
13 Jul 2016 |
162 |
| 34 |
Mitotane Therapy in Adrenocortical Cancer Induces CYP3A4 and Inhibits 5α-Reductase, Explaining the Need for Personalized Glucocorticoid and Androgen Replacement
Vasileios Chortis et al. · The Journal of Clinical Endocrinology & Metabolism
Open access |
16 Nov 2012 |
156 |
| 35 |
The research burden of randomized controlled trial participation: a systematic thematic synthesis of qualitative evidence
Nivantha Naidoo, Van Thu Nguyen, Philippe Ravaud et al. · BMC Medicine
Open access |
19 Jan 2020 |
153 |
| 36 |
Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma
Nelly Burnichon, Alexandre Buffet, Béatrice Parfait et al. · Human Molecular Genetics
|
6 Sep 2012 |
148 |
| 37 |
Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma
Betty Gardie et al. · Journal of Medical Genetics
Open access |
12 Mar 2011 |
145 |
| 38 |
Tuning PID Controller Using Multiobjective Ant Colony Optimization
Chiha Ibtissem, Noureddine Liouane, Pierre Borne · Applied Computational Intelligence and Soft Computing
Open access |
2012 |
144 |
| 39 |
Genomic footprints of activated telomere maintenance mechanisms in cancer
Lina Sieverling et al. · Nature Communications
Open access1,414 authors |
5 Feb 2020 |
143 |
| 40 |
Divergent mutational processes distinguish hypoxic and normoxic tumours
Vinayak Bhandari et al. · Nature Communications
Open access1,328 authors |
5 Feb 2020 |
143 |
| 41 |
Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers Initiative
Jan Bogaerts et al. · European Journal of Cancer
Open access |
24 Dec 2014 |
137 |
| 42 |
2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: report from the working group
Philippe M Debourdeau, D. Kassab Chahmi, Grégoire Le Gal et al. · Annals of Oncology
Open access |
13 Jun 2009 |
135 |
| 43 |
Measuring exposure to the polyphenol metabolome in observational epidemiologic studies: current tools and applications and their limits
Raúl Zamora‐Ros, Marina S. Touillaud, Joseph A. Rothwell et al. · American Journal of Clinical Nutrition
Open access |
May 2014 |
134 |
| 44 |
Epithelial to Mesenchymal Transition Is Activated in Metastatic Pheochromocytomas and Paragangliomas Caused by SDHB Gene Mutations
Céline Loriot, Nelly Burnichon, Noémie Gadessaud et al. · The Journal of Clinical Endocrinology & Metabolism
|
5 Apr 2012 |
132 |
| 45 |
Identification of a CpG Island Methylator Phenotype in Adrenocortical Carcinomas
Olivia Barreau, Guillaume Assié, Hortense Wilmot-Roussel et al. · The Journal of Clinical Endocrinology & Metabolism
|
24 Oct 2012 |
131 |
| 46 |
Sex differences in oncogenic mutational processes
Constance H. Li et al. · Nature Communications
Open access1,376 authors |
28 Aug 2020 |
130 |
| 47 |
6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial
Xavier B. Pivot et al. · The Lancet
Open access346 authors |
Jun 2019 |
129 |
| 48 |
Head and Neck Paragangliomas in Von Hippel-Lindau Disease and Multiple Endocrine Neoplasia Type 2
Carsten C. Boedeker et al. · The Journal of Clinical Endocrinology & Metabolism
Open access |
31 Mar 2009 |
129 |
| 49 |
Isocitrate Dehydrogenase Mutations Are Rare in Pheochromocytomas and Paragangliomas
José Gaal, Nelly Burnichon, Esther Korpershoek et al. · The Journal of Clinical Endocrinology & Metabolism
|
14 Nov 2009 |
127 |
| 50 |
Alcoholic beverages, obesity, physical activity and other nutritional factors, and cancer risk: A review of the evidence
Paule Latino‐Martel, Vanessa Cottet, Nathalie Druesne‐Pecollo et al. · Critical Reviews in Oncology/Hematology
Open access |
15 Jan 2016 |
126 |